Mitral Valve Annuloplasty

• 

  Subject Areas on Research

  • Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair. 
  • Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. 
  • Congenital Double Orifice Mitral Valve Is A Repairable Condition. 
  • Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network 
  • Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation. 
  • Cutting corners. 
  • Dyssynchrony: a different kind of mitral regurgitation. 
  • Evaluation of renal function before and after percutaneous mitral valve repair. 
  • Intraoperative Evaluation of Paravalvular Regurgitation by Transesophageal Echocardiography. 
  • Lung hernia following robotic-assisted mitral valve repair. 
  • Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. 
  • Multimodal Evaluation of Aortic Regurgitation After Mitral and Tricuspid Valve Repairs. 
  • Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? 
  • Pathological Remodeling of Mitral Valve Leaflets from Unphysiologic Leaflet Mechanics after Undersized Mitral Annuloplasty to Repair Ischemic Mitral Regurgitation. 
  • Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms. 
  • Percutanenous therapies for mitral regurgitation. 
  • Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. 
  • Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. 
  • Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. 
  • Reply: Surgical and transcatheter therapy for secondary mitral regurgitation. 
  • Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty". 
  • Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. 
  • The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations. 
  • The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • The outcome of mitral repair for degenerative versus ischemic mitral regurgitation using a single complete ring. 
  • Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. 
  • Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.